NuSkin Enterprises NUS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 69.4%+1.2pp | 68.2%-0.7pp | 68.9%-2.7pp | 71.7%-3.3pp | |
| Operating margin | 4.4%+13.2pp | -8.8%-11.2pp | 2.5%-2.5pp | 5%-3.7pp | |
| Net margin | 10.8%+19.3pp | -8.5%-8.9pp | 0.4%-4.3pp | 4.7%-1.1pp | |
| Returns | |||||
| Return on equity | 22%+41.9pp | -19.9%-20.9pp | 1%-10.6pp | 11.6%-5.7pp | |
| Return on invested capital | 5.9%+20.2pp | -14.3%-16.4pp | 2.1%-7.9pp | 9.9%-4.4pp | |
| Efficiency | |||||
| Asset turnover | 1×0.0× | 1.1×0.0× | 1.1×-0.1× | 1.2×-0.2× | |
| Liquidity | |||||
| Current ratio | 2.1×+0.3× | 1.8×-0.3× | 2.1×0.0× | 2.1×+0.5× | |
| Leverage | |||||
| Debt-to-equity | 0.4×-0.4× | 0.7×0.0× | 0.7×+0.2× | 0.6×0.0× | |
| Net debt / EBITDA | 0.6×— | —— | 2.9×+1.6× | 1.4×+0.9× | |
| Per Share | |||||
| Book value per share | $16.01+22.0% | $13.12-20.4% | $16.49-7.2% | $17.76+0.1% | |
| Valuation | |||||
| Market capitalization | $256.35M-34.9% | $342.51M-64.3% | $959.56M-53.9% | $2.08B-17.6% | |
| Price / earnings | 4.7×+0.8× | —— | 111.6×+91.8× | 19.9×+3.7× | |
| Price / sales | 0.2×-0.1× | 0.2×-0.3× | 0.5×-0.4× | 0.9×0.0× | |
| Price / book | 0.3×-0.2× | 0.5×-0.6× | 1.2×-1.2× | 2.3×-0.4× | |
| EV / EBITDA | 2.8×-7.2× | —— | 11×-1.8× | 12.8×+4.1× | |
| Dividend yield | 4.6%+1.5pp | 3.5%-4.6pp | 8.1%+4.4pp | 3.7%+0.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do NuSkin Enterprises's ratios come from?
- Every ratio is computed from NuSkin Enterprises's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.